Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1684

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 1684
---
 (the “Landon Employment
Agreement”), our Chief Commercial Officer. The term of the Landon Employment Agreement began on February 12, 2024 and will
continue at will, meaning that Ms. Landon or the Company may terminate the employment relationship at any time, with or without
cause, and with or without notice and for any reason or no particular reason. The Landon Employment Agreement provides Ms. Landon an
annual base salary of $300,000, sales bonuses and bonuses to the extent certain events occur or if applicable performance goals are
met and employee benefits that are generally given to our senior executives. Contingent on the receipt of shareholder approval to
increase the number of shares available under the 2022 Plan, Ms. Landon was granted a five-year option to purchase a total of 4,167
shares of our common stock with a per share exercise price to be determined by the Board on the date of grant. The options had a
cashless exercise price and vest annually over five years, with the first vesting date being December 31, 3024. On September 26,
2024, after the receipt of stockholder approval to increase the number of shares available under the 2022 Plan, the
Board approved the grant of the options to Ms. Landon at a per share exercise price of $6.85.  

69

OUTSTANDING
EQUITY AWARDS AT DECEMBER 31, 2024

    Option Awards  
      
    Stock Awards 
  
    Name 
    Number of securities underlying unexercised
    options, exercisable (#)  
    Number of securities underlying unexercised
    options unexercisable (#)  
    Equity incentive plan awards: Number
    of securities underlying unexercised unearned options (#)  
    Option exercise price ($)  
    Option expiration date 
    Number of shares or units of stock
    that have not vested (#)  
    Market value of shares or units of
    stock that have not vested ($) 
  
    Geoffrey
    Dow, President and Chief Executive Officer (Principal Executive Officer)(1)  
     1,000  
             -  
     4,000  
    $60.00  
    July 16, 2034 
           -  
    $        - 
  
    Tyrone
    Miller, Chief Financial Officer (